Transcanna Holdings Inc (TCAN.CX)
0.01
0.00 (0.00%)
CAD |
CNSX |
May 23, 16:00
Transcanna Holdings Shareholders Equity (Quarterly): 2.062M for Aug. 31, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2022 | 2.062M |
| May 31, 2022 | 2.191M |
| February 28, 2022 | 1.606M |
| November 30, 2021 | 3.259M |
| August 31, 2021 | 8.794M |
| May 31, 2021 | 9.071M |
| February 28, 2021 | 7.912M |
| November 30, 2020 | 9.338M |
| Date | Value |
|---|---|
| August 31, 2020 | 15.82M |
| May 31, 2020 | 18.67M |
| February 29, 2020 | 17.44M |
| November 30, 2019 | 16.63M |
| August 31, 2019 | 29.65M |
| May 31, 2019 | 24.02M |
| February 28, 2019 | 1.702M |
| November 30, 2018 | -0.2524M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.606M
Minimum
Feb 2022
29.65M
Maximum
Aug 2019
11.89M
Average
9.205M
Median
Shareholders Equity (Quarterly) Benchmarks
| Biocure Technology Inc | 1.603M |
| Core One Labs Inc | 5.641M |
| Nova Mentis Life Science Corp | -0.601M |
| Nanosphere Health Sciences Inc | -2.064M |
| Lobe Sciences Ltd | -1.235M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.51M |
| Total Liabilities (Quarterly) | 30.44M |